Kerry Marone

Kerry Marone has extensive experience in market development and clinical strategy within the pharmaceutical industry, focusing on obesity and metabolic disorders. Notable positions include roles at Boehringer Ingelheim in market development for obesity and MASH/MASLD, as well as strategic engagement in clinical development and medical affairs. At Ascendis Pharma, Kerry served as Director of Portfolio Market Development. Previous experience at Novo Nordisk involved key responsibilities in strategy and launch readiness for products like Semaglutide, as well as an associate director role in market development in Denmark. Additionally, Kerry held various positions at Takeda Pharmaceuticals, including product manager, associate product manager, and diabetes sales specialist, and began a career as a territory manager at Pharmacia & Upjohn.